Trials / Completed
CompletedNCT05627700
AVL200 IOL for Treatment of Cataract and Presbyopia
A Prospective, Open-label, Single-center Study of the Atia™ AVL200 Modular Intraocular Lens System for Treatment of Cataract and Presbyopia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Atia Vision · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the performance of the AVL200 IOL in terms of visual function improvement over a range of focal points. Participants meeting eligibility criteria will undergo cataract surgery with implantation of the AVL200 intraocular lens (IOL), then be followed through 1 year postoperatively. Postoperative assessments include safety and visual function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AVL200 IOL | The AVL200 is an intraocular lens surgically implanted in the eye after cataract surgery. |
Timeline
- Start date
- 2022-07-25
- Primary completion
- 2025-12-30
- Completion
- 2026-02-10
- First posted
- 2022-11-28
- Last updated
- 2026-02-20
Locations
1 site across 1 country: India
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05627700. Inclusion in this directory is not an endorsement.